On April 10, 2026, BioCardia, Inc. received a notice from Nasdaq that it doesn't meet the minimum stockholders' equity requirement of $2.5 million, having only $895,000 as of December 31, 2025. The company has until May 25, 2026, to submit a plan to regain compliance.